C12N2760/18711 - CPC Classification Index

ClassID:

111018 ⎘

C12N2760/18711 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Paramyxoviridae Rubulavirus, e.g. mumps virus, parainfluenza 2,4

Sub-classes:

C12N2760/18721 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 15
C12N2760/18722 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 31
C12N2760/18723 » Virus like particles [VLP] 5
C12N2760/18731 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 0
C12N2760/18732 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 8
C12N2760/18733 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 3
C12N2760/18734 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 47
C12N2760/18741 » Use of virus, viral particle or viral elements as a vector 7
C12N2760/18751 » Methods of production or purification of viral material 3
C12N2760/18761 » Methods of inactivation or attenuation 4
C12N2760/18771 » Demonstrated in vivo effect 9
C12N2760/18788 » For redistribution 0

Recent Application in this class:

20180369146

METHOD TO PRODUCE A MEDICINAL PRODUCT COMPRISING A BIOLOGICALLY ACTIVE PROTEIN AND THE RESULTING PRODUCT

20180000925

Viral RNA segments as immunomodulatory agents and vaccine components

20150140102

METHOD TO PRODUCE A MEDICINAL PRODUCT COMPRISING A BIOLOGICALLY ACTIVE PROTEIN AND THE RESULTING PRODUCT